The results showed that AKR1C3 was mainly highly expressed in cholangiocarcinoma (CHOL), kidney renal clear cell carcinoma (KIRC), liver hepatocellular carcinoma (LIHC) and lung squamous cell carcinoma (LUSC) (Supplementary Figure S6A). This evidence concerns the gene AKR1C3 and squamous cell lung carcinoma.